SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 24th, 2024 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of April 23, 2024, by and among Cidara Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each purchaser, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SUPPORT AGREEMENTSupport Agreement • April 24th, 2024 • Cidara Therapeutics, Inc. • Biological products, (no disgnostic substances)
This SUPPORT AGREEMENT (this “Agreement”), dated as of April 23, 2024, is made by and among Cidara Therapeutics, Inc., a Delaware corporation (the “Company”) and the other persons and entities set forth on the signature pages hereto (the “Stockholders”). The Company and the Stockholders shall be referred to herein from time to time collectively as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement (as defined below).
